Ambien CR, Razadyne ER Paragraph IV Certifications Filed

The first ANDA with a Paragraph IV certification for Sanofi-Aventis' sleep aid Ambien CR 6.25 mg was filed Feb. 24, according to FDA's May 16 updated list of filings

More from Archive

More from Pink Sheet